These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 32482116)

  • 1. Severity of fetal growth restriction stratified according to maternal obesity.
    Tanner LD; Brock And C; Chauhan SP
    J Matern Fetal Neonatal Med; 2022 May; 35(10):1886-1890. PubMed ID: 32482116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of mid-second trimester fetal growth restriction and associated outcomes.
    Lesser HT; D'Adamo C; O'Reilly G; Arrabal P; Ehsanipoor RM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10168-10172. PubMed ID: 36100267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chemotherapy during pregnancy on fetal growth.
    Maggen C; Wolters VERA; Van Calsteren K; Cardonick E; Laenen A; Heimovaara JH; Mhallem Gziri M; Fruscio R; Duvekot JJ; Painter RC; Masturzo B; Shmakov RG; Halaska M; Berveiller P; Verheecke M; de Haan J; Gordijn SJ; Amant F;
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10314-10323. PubMed ID: 36202393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).
    ; Martins JG; Biggio JR; Abuhamad A
    Am J Obstet Gynecol; 2020 Oct; 223(4):B2-B17. PubMed ID: 32407785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of late-onset fetal growth restriction: pragmatic approach.
    Peasley R; Rangel LAA; Casagrandi D; Donadono V; Willinger M; Conti G; Seminara Y; Marlow N; David AL; Attilakos G; Pandya P; Zaikin A; Peebles D; Napolitano R
    Ultrasound Obstet Gynecol; 2023 Jul; 62(1):106-114. PubMed ID: 36864542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in body composition and growth persist postnatally in fetuses diagnosed with severe compared to mild fetal growth restriction.
    Hesse H; Palmer C; Rigdon CD; Galan HL; Hobbins JC; Brown LD
    J Neonatal Perinatal Med; 2022; 15(3):589-598. PubMed ID: 35342050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Maternal Obesity on Neonatal Outcomes of Pregnancies Complicated by Fetal Growth Restriction.
    Whelan AR; Esposito M; Lord MG
    Am J Perinatol; 2024 May; 41(S 01):e2184-e2187. PubMed ID: 37225127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes among Neonates after a Diagnosis of Persistent or Transient Fetal Growth Restriction Delivered at Term.
    Ramos SZ; Has P; Gimovsky AC; Danilack VA; Savitz DA; Lewkowitz AK
    Am J Perinatol; 2024 May; 41(S 01):e1470-e1477. PubMed ID: 36894159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus?
    Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):210-216. PubMed ID: 31381215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal plasma soluble neuropilin-1 is downregulated in fetal growth restriction complicated by abnormal umbilical artery Doppler: a pilot study.
    Porter B; Maulik D; Babbar S; Schrufer-Poland T; Allsworth J; Ye SQ; Heruth DP; Lei T
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):716-721. PubMed ID: 33533520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal growth restriction and small for gestational age as predictors of neonatal morbidity: which growth nomogram to use?
    Leon-Martinez D; Lundsberg LS; Culhane J; Zhang J; Son M; Reddy UM
    Am J Obstet Gynecol; 2023 Dec; 229(6):678.e1-678.e16. PubMed ID: 37348779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse intrapartum outcome in pregnancies complicated by small for gestational age and late fetal growth restriction undergoing induction of labor with Dinoprostone, Misoprostol or mechanical methods: A systematic review and meta-analysis.
    Familiari A; Khalil A; Rizzo G; Odibo A; Vergani P; Buca D; Hidaka N; Di Mascio D; Nwabuobi C; Simeone S; Mecacci F; Visentin S; Cosmi E; Liberati M; D'Amico A; Flacco ME; Martellucci CA; Manzoli L; Nappi L; Iacovella C; Bahlmann F; Melchiorre K; Scambia G; Berghella V; D'Antonio F
    Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():455-467. PubMed ID: 32738675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case-control study.
    Ego A; Monier I; Skaare K; Zeitlin J
    Ultrasound Obstet Gynecol; 2020 May; 55(5):613-620. PubMed ID: 31364201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal abdominal circumference in the second trimester and prediction of small for gestational age at birth.
    Doulaveris G; Gallagher P; Romney E; Richley M; Gebb J; Rosner M; Dar P
    J Matern Fetal Neonatal Med; 2020 Jul; 33(14):2415-2421. PubMed ID: 30482067
    [No Abstract]   [Full Text] [Related]  

  • 16. Infant outcome after active management of early-onset fetal growth restriction with absent or reversed umbilical artery blood flow.
    Morsing E; Brodszki J; Thuring A; Maršál K
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):931-941. PubMed ID: 32862450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical Venous Volume Flow in Late-Onset Fetal Growth Restriction.
    Hamidi OP; Driver C; Steller JG; Peek EE; Monasta L; Stampalija T; Gumina DL; DeVore GR; Hobbins JC; Galan HL
    J Ultrasound Med; 2023 Jan; 42(1):173-183. PubMed ID: 35451119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal outcome after persistence of abnormal umbilical artery Doppler indices in the growth-restricted fetus following betamethasone administration.
    Prasannan L; Blitz MJ; Augustine S; Kohn N; Rochelson B; Pessel C
    J Matern Fetal Neonatal Med; 2022 Sep; 35(18):3620-3625. PubMed ID: 33108909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Outcomes among Fetuses with an Abdominal Circumference <3rd %ile and Estimated Fetal Weight 3rd to 9th %ile Compared to Fetuses with an EFW <3rd %ile.
    Horgan R; Nehme L; Jensen HJ; Shah AP; Saal R; Onishi K; Kawakita T; Martins JG; Abuhamad A
    Am J Perinatol; 2024 Jul; 41(9):1120-1125. PubMed ID: 38301725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of deterioration of umbilical artery Doppler indices in fetuses with severe early-onset fetal growth restriction.
    Martins JG; Kawakita T; Barake C; Gould L; Baraki D; Connell P; Sinkovskaya E; Abuhamad A
    Am J Obstet Gynecol MFM; 2024 Mar; 6(3):101283. PubMed ID: 38219949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.